Eliquis

News

BMS, Pfizer take DTC route for blood thinner Eliquis

BMS, Pfizer launch direct-to-patient sales for anticoagulant Eliquis, as a report cites conflict-of-interest concerns about the emerging DTC channel.

News

BMS files legal challenge to HHS' 340B rebate decision

Bristol-Myers Squibb has become the latest pharma in the US to file a legal challenge to a block on a 340B drug rebate model opposed by HRSA.

News

Pfizer's COVID boom goes on, as it eyes $22bn in Paxlovid sa...

Pfizer reckons it will make a whopping $22 billion in sales of its oral COVID-19 antiviral Paxlovid in 2022, with another $32 billion from its BioNTech-partnered coronavirus vaccine Comirna

BMS, Pfizer take DTC route for blood thinner Eliquis

BMS files legal challenge to HHS' 340B rebate decision

Pfizer's COVID boom goes on, as it eyes $22bn in Paxlovid sa...

FDA clears Viridian's Tepezza rival for thyroid eye disease

Discover a new era of healthcare panel engagement: Grounded ...

Editor's Picks